Genome
发表于 2025-3-25 07:11:28
Tumor Infiltrating Lymphocytes in Human Renal Cell Carcinoma: Adoptive Immunotherapy and Characterizs with reactivity to the autologous tumor . Most of the infiltrating cells are X lymphocytes, with the number of CD8+ cells being greater than CD4+ cells . Several human solid tumors have been reported to contain an increased frequency of cytotoxic precursors against autologous tumor when
nephritis
发表于 2025-3-25 11:32:39
http://reply.papertrans.cn/47/4624/462312/462312_22.png
并排上下
发表于 2025-3-25 14:44:42
Interferon and Tumor Necrosis Factor in Renal Cell Carcinoma Model Systemsear after discovery. Advanced RCC is refractory to nearly all forms of systemic therapy. Hormonal therapy may result in a small proportion (0%–10%) of objective responses, but these are incomplete and of short duration. Single or combination chemotherapy also yields no clearly definable improvement in patient survival .
辩论的终结
发表于 2025-3-25 16:18:44
Rationale for Immunotherapy in Renal Cell Carcinomaourse of their disease. Some 80% of the patients with disseminated disease will die within 3 years after surgery whereas 65% of patients with localized disease survive at least 5 years after diagnosis
FAST
发表于 2025-3-25 22:06:33
http://reply.papertrans.cn/47/4624/462312/462312_25.png
骚扰
发表于 2025-3-26 03:34:50
http://reply.papertrans.cn/47/4624/462312/462312_26.png
断言
发表于 2025-3-26 08:19:30
http://reply.papertrans.cn/47/4624/462312/462312_27.png
LINE
发表于 2025-3-26 08:32:13
Tumor Infiltrating Lymphocytes in Human Renal Cell Carcinoma: Adoptive Immunotherapy and Characterizcompared with peripheral blood lymphocytes . In addition, recent studies have shown that TELs were therapeutically more potent than interleukin (IL)-2-activated spleen cells in several murine tumor models .
内阁
发表于 2025-3-26 15:31:09
http://reply.papertrans.cn/47/4624/462312/462312_29.png
议程
发表于 2025-3-26 16:53:01
http://reply.papertrans.cn/47/4624/462312/462312_30.png